Overview

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
To compare the antidepressant efficacy and safety of DVS-233 SR versus placebo in adult outpatients with MDD.
Phase:
Phase 3
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Venlafaxine Hydrochloride